Type Here to Get Search Results !

Information about all covid vaccines in the world

Information about all covid vaccines in the world

From the beginning of the pandemic, the greatest effort of all scientists from around the world is to develop a safe vaccine against new coronavirus. To ensure maximal safety, only EU-approved vaccines are allowed for usage in most places 


Information about all covid vaccines in the world





A vaccine against Covid-19 is a drug protecting given individual from the disease caused by the new coronavirus SARS-CoV-2 by inducing immune system reaction against the virus. In layman’s terms, the vaccine learns the body where are the weaknesses of the virus and how to produce adequate immune system reaction so that your immune system could kill the virus before its reproduction in the body.

Four of the existing vaccines are registered in the EU so far.
Overview of existing vaccines

Vaccines approved by EMA for the usage within the EU member states:

COMIRNATY

Manufacturer: Pfizer/BioNTech
Vaccine type: mRNA, coated with lipid nanoparticles.
Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.
Registered in EU: 21.12.2020
number of doses per person: 2
The interval between the doses according to SPC: 21 days
Approved age limit for usage: +5
Vaccination cannot induce Covid-19 disease as the vaccine does not include a live virus.
More can be found in the State Institute for Drug Control press report.
4.10. The EMA approved (only in Czech) an additional dose of Comirnaty for people with weakened immunity at least 28 days after the second dose and a booster dose of Comirnaty for people aged 18-55 years at least 6 months after the second dose.
25.11.EMA recommended the Comirnaty vaccine (only in Czech) for vaccination of children aged 5-11 years. 26.11. The European Commission approved the recommendation. Children will be vaccinated with a reduced dose.
Based on the decision of the Ministry of Health (only in Czech) on 29.11., the booster dose will be administered to those at risk and those over 60 years of age 5 months after the end of the basic vaccination schedule.

SPIKEVAX

  • Manufacturer: Moderna
  • Vaccine type: mRNA, coated with lipid nanoparticles
  • Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the2nd dose.
  • Registered in EU: 6.1.2021
  • Number of doses per person: 2
  • The interval between the doses according to SPC: 28 days
  • Approved age limit for usage: 12+
  • Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses.
  • More can be found in the State Institute for Drug Control press report.
  • 4.10. The EMA approved an additional dose of Spikevax for people with weakened immunity at least 28 days after the second dose.
  • Based on the decision of the Ministry of Health (only in Czech) on 29.11., the booster dose will be administered to those at risk and those over 60 years of age 5 months after the end of the basic vaccination schedule.

VAXZEVRIA

Manufacturer: AstraZeneca
Vaccine type: vector-based (adenovirus ChAdOx1)
Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.
Registered in EU: 29.1.2021
Number of doses per person: 2
The interval between the doses according to SPC: 28 - 84 days
Approved age limit for usage: +18 (Recommended for individuals +60 based on Ministry of Health press report)
Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses. Adenovirus modification precludes any possibility of inducing the Covid-19 disease.
More can be found in the State Institute for Drug Control press report.

JANSSEN

Manufacturer: Janssen Pharmaceutica (Johnson & Johnson)
Vaccine type: vector-based (adenovirus Ad26)
Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from vaccination
Registered in EU: 11.3.2021
Number of doses per person: 1
Approved age limit for usage: +18 (Recommended for individuals +60 based on Ministry of Health press report)
Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses. Adenovirus modification precludes any possibility of inducing the Covid-19 disease.
More can be found in the State Institute for Drug Control press report.
At ockoreport.uzis.cz you can find information on how to reschedule an inconvenient vaccination date for each vaccination site.
Vaccines under EMA assessment procedure for the use in the EU:

NUVAXOVID (former NVX-COV2373)

Manufacturer: Novavax
Vaccine type: protein-based, adjuvanted
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 3.2.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.
The EMA is currently considering a conditional marketing authorization (only in Czech) application for this vaccine.

SPUTNIK V (Gam-COVID-Vac)

Manufacturer: Nikolai Gamalei Institute of Epidemiological and Microbiological Research, Moscow
Vaccine type: vector-based (adenovirus rAd26 a rAd5)
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 4.3.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.

VERO CELL (CoronaVac)

Manufacturer: Sinovac
Vaccine type: inactivated viral, adjuvanted
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 4.5.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.

VIDPREVTYN

Manufacturer: Sanofi Pasteur/GlaxoSmith
Kline
Vaccine type: protein-based, adjuvanted
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 20.7.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.

  • VLA2001

Manufacturer: Valneva
Vaccine type: inactivated viral, adjuvanted
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 20.7.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.
Vaccines where the EMA approval process has been stopped

CVNCOV

Manufacturer: CureVac
Vaccine type: mRNA, coated with lipid nanoparticles
Recognized for the EU COVID digital certificate: no
Assessment procedure start: 12.2.2021
Number of doses per person: 2
State Institute for Drug Control press report regarding assessment procedure start.
The approval was stoppedfollowing a request from CureVac (only in Czech)
Patent-compliant vaccines approved by the EMA and also approved by the WHO for emergency use

COVISHIELD

This is an Indian production of AstraZeneca vaccine.
Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.
The overview and status of the Covid-19 vaccines are regularly released by WHO.

Top Post

Below Post